Bio Pharma Dive
NOVEMBER 22, 2024
The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market that investors have been skeptical BridgeBio can win.
Pharmaceutical Technology
NOVEMBER 22, 2024
Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J&J) CARVYKTI for multiple myeloma treatment.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 22, 2024
The restructuring follows the company's receipt of a letter from the FDA citing "deficiencies" in its approval application for diabetes drug Zynquista.
Pharmaceutical Technology
NOVEMBER 22, 2024
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
NOVEMBER 22, 2024
Despite plans to shutter 1,200 stores, the company’s chief clinical trials officer said the pharmacy giant remains committed to aiding drug research.
Pharmaceutical Technology
NOVEMBER 22, 2024
The biotech uses its AI platform to discover the therapeutic potential of plant-based molecules, advancing ten candidates with the funds.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
NOVEMBER 22, 2024
Zai Lab and Pfizer have entered a strategic collaboration for the commercialisation of XACDURO in mainland China.
Cloudbyz
NOVEMBER 22, 2024
Cloudbyz Achieves Key Recognition in Everest Group’s 2024 PEAK Matrix® for Life Sciences Clinical Trial Management System (CTMS) Products Naperville, IL, November 22, 2024 – Cloudbyz, a leader in cloud-based clinical trial management solutions, proudly announces its recognition in the 2024 Everest Group PEAK Matrix® for Life Sciences Clinical Trial Management System (CTMS) solutions.
Pharmaceutical Technology
NOVEMBER 22, 2024
Novartis has announced the acquisition of Kate Therapeutics to enhance its portfolio of gene therapies for inherited neuromuscular diseases.
Medical Xpress
NOVEMBER 22, 2024
An international research team, led by the University of Wollongong (UOW), has found wearable organic X-ray sensors could offer safer radiotherapy protocols for cancer patients.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
NOVEMBER 22, 2024
Johnson & Johnson Innovation Medicine has submitted a request to the FDA to approve Tremfya as a treatment for ulcerative colitis.
Medical Xpress
NOVEMBER 22, 2024
LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.
Pharmaceutical Technology
NOVEMBER 22, 2024
The UK’s proposed regulations would provide the legal framework for POC manufacturing of cell therapies, including quality assurance.
pharmaphorum
NOVEMBER 22, 2024
The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Pharmaceutical Technology
NOVEMBER 22, 2024
Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly than traditional pressurised metered-dose inhalers (pMDIs).
Medical Xpress
NOVEMBER 22, 2024
A 57-year-old woman with COPD has received the world's first fully robotic double lung transplant.
Pharmaceutical Technology
NOVEMBER 22, 2024
Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches.
Medical Xpress
NOVEMBER 22, 2024
Children's books are full of animal characters whose antics capture the hearts and inspire the imaginations of their young readers.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
NOVEMBER 22, 2024
TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.
pharmaphorum
NOVEMBER 22, 2024
Community pharmacies play a crucial role in bridging health inequalities and empowering communities. Learn how the NHS and community pharmacies work together to improve health outcomes for all.
Medical Xpress
NOVEMBER 22, 2024
Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report. Smokers and drinkers, as well as those with HPV infections, are disproportionately affected.
pharmaphorum
NOVEMBER 22, 2024
AstraZeneca is facing some pushback as it tries to upgrade anticoagulant antidote drug Andexaa to full approval in the US.
Medical Xpress
NOVEMBER 22, 2024
Adolescents who snore frequently were more likely to exhibit behavior problems such as inattention, rule-breaking, and aggression, but they do not have any decline in their cognitive abilities, according to a new study conducted by researchers at the University of Maryland School of Medicine (UMSOM).
pharmaphorum
NOVEMBER 22, 2024
Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Medical Xpress
NOVEMBER 22, 2024
The spread of tumor from the primary cancer site to distant organs, called metastasis, has puzzled scientists for many years—they are only now beginning to pinpoint triggers and mechanisms that drive this process.
Fierce Pharma
NOVEMBER 22, 2024
After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue growth among the top companies in the biopharma industry, there was a new champion in the | After six straight quarters in which Eli Lilly or Novo Nordisk achieved the highest year-over-year revenue increases among the top companies in the biopharma industry, there was a new growth champion in the third quarter.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Medical Xpress
NOVEMBER 22, 2024
Worn down by pandemic-era vaccine overload, many Americans are ignoring pleas by health officials to get immunized against the flu and COVID-19, new data shows.
Fierce Pharma
NOVEMBER 22, 2024
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact fkansteiner Fri, 11/22/2024 - 09:04
Medical Xpress
NOVEMBER 22, 2024
Researchers at Penn State are using machine learning and existing electrocardiogram (ECG) data to help doctors make more accurate predictions. A team of artificial intelligence engineers, in collaboration with a team of physicians from Penn State Heart and Vascular Institute, is working to develop novel algorithms for point-of-care, in-house use and for technology licensing.
Fierce Pharma
NOVEMBER 22, 2024
For many biopharmas, it takes years of hard work to transition from being a clinical-stage drugmaker to a commercial one. Companies rarely want to make the shift back. | The pivot comes after the FDA issued a notice that the deficiencies in the company's approval bid for type 1 diabetes med Zynquista are too great to proceed for further discussion.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
310 
Let's personalize your content